ANKRD49 and metastatic malignant neoplasm in the lymph nodes: Our previous study using microarray analysis combined with IHC staining of tissue from 160 NSCLC patients, including 80 LUAD cases and 80 LUSC cases, showed that ANKRD49 is highly expressed in cancerous lung tissues and correlates with lymph node metastasis, distal metastasis, TNM stage, and differentiation in NSCLC patients.